Abbott Laboratories 

$109.58
3730
+$0.28+0.26% Today

Statistics

Day High
109.48
Day Low
105.68
52W High
140.22
52W Low
106.05
Volume
15,536,344
Avg. Volume
7,883,560
Mkt Cap
190.55B
P/E Ratio
15.53
Dividend Yield
2.31%
Dividend
2.53

Upcoming

Dividends

2.31%Dividend Yield
Feb 26
$0.63
Nov 25
$0.59
Aug 25
$0.59
May 25
$0.59
Feb 25
$0.59
10Y Growth
9.25%
5Y Growth
6.96%
3Y Growth
7.3%
1Y Growth
6.78%

Earnings

22AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.07
1.21
1.36
1.5
Expected EPS
1.153064
Actual EPS
N/A

Financials

31.95%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
83.9BRevenue
26.8BNet Income

Analyst Ratings

$141.00Average Price Target
The highest estimate is 169.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap9.49B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap136.19B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap36.04B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.
Hologic
HOLX
Mkt Cap16.45B
Hologic competes with Abbott in the diagnostics sector, particularly in women's health, where both companies offer a range of diagnostic and medical imaging solutions.

About

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Show more...
CEO
Mr. Robert B. Ford
Employees
114000
Country
US
ISIN
US0028241000

Listings

0 Comments

Share your thoughts

FAQ

What is Abbott Laboratories stock price today?
The current price of ABT is $109.58 USD — it has increased by +0.26% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABT.
Is Abbott Laboratories stock price growing?
ABT stock has risen by +0.67% compared to the previous week, the month change is a -11.83% fall, over the last year Abbott Laboratories has showed a -14.41% decrease.
What is Abbott Laboratories market cap?
Today Abbott Laboratories has the market capitalization of 190.55B
When is the next Abbott Laboratories earnings date?
Abbott Laboratories is going to release the next earnings report on April 22, 2026.
What were Abbott Laboratories earnings last quarter?
ABT earnings for the last quarter are 1.5 USD per share, whereas the estimation was 1.5 USD resulting in a +0.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbott Laboratories revenue for the last year?
Abbott Laboratories revenue for the last year amounts to 83.9B USD.
What is Abbott Laboratories net income for the last year?
ABT net income for the last year is 26.8B USD.
Does Abbott Laboratories pay dividends?
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.59 USD. As of today, Dividend Yield (FWD)% is 2.31%.
How many employees does Abbott Laboratories have?
As of February 02, 2026, the company has 114,000 employees.
In which sector is Abbott Laboratories located?
Abbott Laboratories operates in the Health Care sector.
When did Abbott Laboratories complete a stock split?
The last stock split for Abbott Laboratories was on June 01, 1998 with a ratio of 2:1.
Where is Abbott Laboratories headquartered?
Abbott Laboratories is headquartered in North Chicago, US.